Press Releases

Mithra Announces Myring™ Update
14 December 2018
EN FR

Mithra Announces Positive Results of Ovarian Function Sub-Study which Strengthens Estelle® Contraceptive Efficacy Profile
6 December 2018
EN FR

Mithra Reduces Environmental Impact of CDMO facility in Belgium with the Installation of 1800 Solar Panels
21 November 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for Vaginal Contraceptive Ring in Australia and New Zealand
20 November 2018
EN FR

Full Estetrol (E4) Program Update Provided at Scientific Advisory Board Meetings
19 November 2018
EN FR

Mithra Announces the Completion of its Lead Clinical Phase III Programme for Estelle®
14 November 2018
EN FR

New Warrant Plan Approved by Mithra Shareholders
6 November 2018
EN FR

2018 Update and 2019 Outlook Given at the CPHI Conference
10 October 2018
EN FR

Notice of 2018 Extraordinary General Meeting Regarding Proposed Warrant Plan
5 October 2018
EN FR

Presentation of Donesta® PhIIb Results at the 2018 Annual Meeting of the North American Menopause Society
3 October 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for the Commercialization of Myring™ in Chile with Laboratorio Pasteur
27 September 2018
EN FR

Mithra Announces 2018 Half Year Results
25 September 2018
EN FR

Interim Financial Report as at 30 June 2018
25 September 2018
EN FR

Mithra Finalizes Contract for the Commercialization of Estelle® with South Korean Women’s Health Leader Hyundai Pharm
24 September 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for Commercialization of Tibelia® in Taiwan
21 September 2018
EN FR

Mithra announces further details regarding contract Gedeon Richter
12 September 2018
EN FR

Press conference – Estelle – Gedeon Richter
12 September 2018
EN

Mithra and Richter Sign License and Supply Agreement for Commercialization of Estelle®, a Novel Oral Contraceptive
12 September 2018
EN FR

Mithra Announces Positive Top-Line Results of Estelle® Phase III Oral Contraceptive Study in EU/Russia
8 August 2018
EN FR

Mithra Announces Belux Agreement with Ceres Pharma Worth over EUR 40 Million
30 July 2018
EN FR

Mithra Obtains First Marketing Authorization for Myring™ in Europe
20 July 2018
EN FR

Mithra and Mediner Sign LSA for Tibelia® in Hungary
13 July 2018
EN FR

Publication of a Transparency Notification Received from François Fornieri
4 July 2018
EN FR

Publication of a Transparency Notification Received from Meusinvest SA
4 July 2018
EN FR

Mithra and Orifarm Sign LSA for Vaginal Contraception Ring in Denmark
21 June 2018
EN FR

Mithra Announces Presentation of Donesta® Results at the International Menopause Society’s 16th World Congress
8 June 2018
EN FR

Information on the total number of voting rights (denominator)
5 June 2018
EN FR

Mithra Signs Binding Heads of Terms for Commercialization of Estelle® in South Korea with Women’s Health Specialist Hyundai Pharm
5 June 2018
EN FR

Mithra Successfully Raises EUR 77.5 Million
31 May 2018
EN FR

Mithra Announces Further Positive Phase IIb Donesta® Efficacy and Safety Data
30 May 2018
EN FR

Mithra Launches Capital Increase by Means of a Private Placement via an Accelerated Bookbuild Offering
30 May 2018
EN FR

Update on Mithra and Mayne Pharma’s Vaginal Contraceptive Ring Opportunity
28 May 2018
EN FR

Mithra Announces Injectable Contract with Midas Pharma
16 May 2018
EN FR

Mithra Announces Last Subject Visit in Estelle® Phase III Study in EU/Russia and Completion of Endometrial Substudy
3 May 2018
EN FR

Mithra Announces Positive Donesta® Phase IIb Study Achieving Primary Objective and Confirming Promising Safety Profile
19 April 2018
EN FR

Mithra releases 2017 Annual Report and invitation to its Ordinary General Shareholders’ Meeting
16 April 2018
EN FR

Annual Report 2017
16 April 2018
EN FR

Mithra Signs Principle Agreement for Commercialization of Estelle® in Canada with Women’s Health Specialist Searchlight Pharma
12 April 2018
EN FR

Mithra Applies for Additional Estelle® Patent Based on Positive Hemostasis Data
28 March 2018
EN FR

Mithra Announces Completion of Estelle® Cycles Required in Phase III Contraception Studies
23 March 2018
EN FR

Mithra and Mayne Pharma’s Vaginal Contraceptive Ring Accepted for Filing by FDA
20 March 2018
EN FR

Mithra and Alvogen Sign LSA for Vaginal Contraception Ring in Russia
16 March 2018
EN FR

Mithra Presents Positive Hemostasis Results at ISGE Conference
8 March 2018
EN FR

Mithra Reports 2017 Annual Results
2 March 2018
EN FR

Mithra Announces Very Promising Hemostasis Results for Estelle®
8 February 2018
EN FR

Mithra Announces Last Subject Completes Donesta® Phase II Study
25 January 2018
EN FR

Mithra announces 2018 financial calendar
17 January 2018
EN FR